Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Technology is innovation and looks likely to form the foundation for much of our society for the foreseeable future. Technology. Financial sector.

Health Care 66

Health Care Biotechnology Energy Insurance 66

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. They raised more money and were acquired at higher valuations; however, they did not innovate more.

Biotechnology 49

Biotechnology Human Capital Travel Entrepreneur 49

Strategy Driven

MAY 12, 2021

Similarly, the increased development of 3D games, 3D mobile devices, and 3D movies has stimulated the demand for true 3D displays both in consumer and enterprise applications. Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential.

Technology 98

Technology Content Video Globalization 98

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 11

Globalization Innovation Decentralization Chemicals 11

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Venture Capitalist 10

Venture Capitalist Innovation Company Supply Chain 10

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 26, 2011

Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 14

Energy Finance IPO Biotechnology 14

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 15

Globalization Marketing Venture Capitalist Biotechnology 15

Harvard Business Review

OCTOBER 1, 2014

The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.)

Entrepreneur 15

Entrepreneur Biotechnology Real Estate Long-term 15

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Develop Creative Discontent. Find Pivots.

Skills 11

Skills Power Six Sigma Disruptive Innovation 11

Harvard Business Review

MARCH 1, 2012

Second, the bigger CMOs tend to have specialized skills and knowledge that can help their partners innovate. For example, in biotechnology, a field in which the U.S. innovation" typically means just one thing to people: novel gadgets. Third, they create jobs — really good, high-paying jobs. In the U.S.,

Contract Manufacturing 10

Contract Manufacturing Offshoring Supply Chain Biotechnology 10

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. Not innovation, risk management, technology, debt, or the regulatory environment. Not competitive threats. Not rising costs.

Talent Management 10

Talent Management Company Telecommunications Management 10

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. Many wealthy societies have low human-development scores (e.g., It pledges $1.5 The contrast between the U.N.'s

First-mover Advantage 10

First-mover Advantage GDP Technology Biotechnology 10

Harvard Business Review

MARCH 5, 2012

Indian companies, for instance, are already doing quite well exporting services like software development, technical support, and back-office processing to America. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. The Right Policies.

Health Care 10

Health Care Biotechnology Industry Policies 10

Harvard Business Review

MARCH 8, 2013

government, which through DARPA and other initiatives stands out worldwide for its astoundingly positive track record in funding true innovation. Even development banks in emerging economies, like China and Brazil, are doing more than Silicon Valley-type "entrepreneurs.". Yet it's a capitalism impossible to conceive of without the U.S.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Technology 8

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. Google got its start from a federal grant. ” Yet that poses a problem for managers.

Company 8

Company Innovation Competitive Advantage White Paper 8

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JUNE 4, 2018

.’s “once unchallenged preeminence in commerce, industry, science, and technological innovation is being overtaken by competitors throughout the world.” ” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” industries face acute skills shortages. .

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

JUNE 16, 2016

The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 3, 2015

Make you more innovative. By managing the three key properties of networks that either propel you forward or hold you back—breadth, connectivity, and dynamism—you can develop a stronger network and use it as an essential leadership tool. The result was that their ideas were not developed. It can keep you informed.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MARCH 30, 2017

The AEM cube, a tool developed by Peter Robertson, a psychiatrist and business consultant, assesses differences in the way people approach change. We worked with a startup biotechnology company. It cannot be predicted or easily orchestrated. When its R&D team members tried our strategy execution task, they performed terribly.

Diversity 8

Diversity Team Biotechnology Execution 8

Strategy Driven

OCTOBER 19, 2024

In a rapidly evolving digital landscape, biotechnology companies face the challenge of making their websites stand out. A solid online presence is crucial for conveying the complexities of biotech innovations while attracting stakeholders. Conclusion A standout website is a crucial differentiator in the competitive biotechnology field.

Biotechnology 93

Biotechnology Storytelling Audience Core Competence 93

The Horizons Tracker

FEBRUARY 6, 2025

Market opportunities, timing, and strong entrepreneurial foundations are key to building successful “university innovation entrepreneurial ecosystems” (UIEEs) like Silicon Valley, according to research from the Keck Graduate Institute. However, being ready to act when it does take off is crucial.

Venture Capitalist 71

Venture Capitalist Biotechnology How To Entrepreneur 71

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Customers Innovation Technology'

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

NOVEMBER 9, 2016

However, I fear that Mexico continuing its existing trade-based economic strategy will not necessarily produce different results in the long term — as it wouldn’t for any other developing country. For instance, breeding programs have developed cows to produce milk that is low in fat and high in omega-3 oils. When the U.S.

Cooper 15

Cooper Long-term Industry Health Care 15